Abstract

Fenofibrate (FF) is a lipid-lowering agent classified in the biopharmaceutics classification system (BCS) class II with lower solubility and higher permeability. This research work deals with developing FF containing liquid self-micro emulsifying drug delivery system (L-SMEDDS) and converting it into solid SMEDDS (S-SMEDDS) using a lyophilization technique followed by the manufacturing of tablets with enhanced solubility and dissolution rate. L-SMEDDS of FF were manufactured using Tween 80, oleic acid, and transcutol. With the help of the lyophilization technique, this L-SMEDDS was converted to S-SMEDDS using microcrystalline cellulose and finally, immediate-release tablets were developed using S-SMEDDS. The L-SMEDDS showed excellent stability due to zeta potential of -1.69 mV and a globule size of 250 μm. The lyophilized S-SMEDDS of FF showed nearly 58-fold solubility enhancement in distilled water in comparison to pure FF due to the formation of amorphous material confirmed in the X-ray diffraction (XRD) study. The F9 formulation showed 100% drug release within 40 minutes with enhanced dissolution properties compared to conventional tablets. The optimized formulation was robust and stable at the accelerated condition for 3 months. The current research work demonstrates lyophilization as a potential approach to convert the L-SMEDSS to a S-SMEDDS with an enhanced solubility and dissolution rate.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.